Research, Select, & Monitor Thursday, October 18, 2018 6:21:13 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Omeros Corp$15.33($.12)(.78%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Omeros Corp vs Chemicals - Major Diversified

Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.

Looking at a few key industries, such as chemical manufacturing, one can usually summarize the strength of a nationís economy. So many industries rely on the raw products of these companies. Fuel additives and detergents are probably the most common encounter we have with products from these firms. They also produce pharmaceuticals, polymers, resins, monomers, plastics, agricultural chemicals, and industrial gases. Just a few of the industries that use these items are aerospace, beverage, electronic, food processing, automotive, and construction.
 Totals Company Industry
  Sales: $64.8 Mil $87,873.0 Mil
  Market Cap: $747.5 Mil $238,005.5 Mil
  Analysts Recommendation: Buy Buy

 Averages Company Industry
  Historic Revenue: 55.8% 3.6%
  Estimated Revenue: (76.2%) 20.8%
  Historic Earnings: N/A 7.6%
  Estimated Earnings: N/A 18.9%
  Stock Price (1 Year): (20.8%) (3.0%)
  Cash per Share: 36.5% 34.6%
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: N/A 15.6
  Price-to-Sales: 19.3 N/A
  Price-to-Book: (263.9) 3.5
  Dividend Yield: N/A N/A
  Market Cap: $747.5 Mil $26,445.1 Mil
  Net Margin: (181.5%) 11.6%
  Gross Margin: 98.3% 38.6%
  Return on Equity: N/A .2
  Return on Assets: (.5) .1
  Balance Sheet
  Current Ratio: 4.1 1.5
  Quick Ratio: 4.1 1.1
  Cash Ratio: 3.2 .2
  Debt-to-Equity: N/A 1.9
  Interest Coverage: .1 .3
  Relative-Strength Index: 37.2 N/A

 Other companies in Chemicals - Major Diversified Price Market Cap
  L'Air Liquide ADR  (AIQUY) $24.57 $52,463.8 Mil
  Praxair, Inc.  (PX) $159.79 $46,484.2 Mil
  Henkel KGaA  (HENKY) $98.74 $42,787.3 Mil
  Air Products & Chemicals, Inc.  (APD) $159.48 $34,969.2 Mil
  Akzo Nobel N.V.  (AKZOY) $29.12 $22,091.0 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2018 All rights reserved.